NLTX · Categories · Form 3
NLTX - SEC Form 3 initial insider statements
Neoleukin Therapeutics Inc. (NLTX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for NLTX
- SEC Form 3 filed by new insider Jordan Julie3 - Neurogene Inc. (0001404644) (Issuer)
- New insider Cvijic Christine Mikail claimed ownership of 20,941 shares (SEC Form 3)3 - Neurogene Inc. (0001404644) (Issuer)
- New insider Mcminn Rachel claimed ownership of 1,250,359 shares (SEC Form 3)3 - Neurogene Inc. (0001404644) (Issuer)
- SEC Form 3 filed by new insider Woods Robert Keith3 - Neurogene Inc. (0001404644) (Issuer)
- SEC Form 3 filed by new insider Baffi Robert3 - Neurogene Inc. (0001404644) (Issuer)
- SEC Form 3 filed by new insider Cobb Stuart3 - Neurogene Inc. (0001404644) (Issuer)
- SEC Form 3 filed by new insider Freedland Cory S.3 - Neurogene Inc. (0001404644) (Issuer)
- SEC Form 3 filed by new insider Cochener Donna3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
- SEC Form 3 filed by new insider Palekar Rohan3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
- SEC Form 3: New insider Smith Sean Michael claimed ownership of 3,431 shares3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
- SEC Form 3 filed by Patel Priti3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
- SEC Form 3: Carl Walkey claimed ownership of 1,385,962 units of Common Stock3 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)